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1. Introduction 
The peptide hormones insulin and glucagon are 
both involved in regulating blood glucose levels. They 
each interact with specific receptors exposed at the 
external surface of the plasma membrane [I]. Whilst 
the molecular action of glucagon at the level of the 
plasma membrane in activating adenylate cyclase is 
relatively well understood [2,3], that of insulin is 
poorly appreciated [ 1,4]. However, very recently 
there have been claims that insulins occupancy of its 
receptor leads to the production of a ‘peptide-like’ 
‘second messenger’ [S--7],. This fraction can mimic 
the action of insulin in decreasing the phosphoryla- 
tion of mitochondrial pyruvate dehydrogenase in 
adipocytes [5,6], converting the enzyme from an 
inactive, phosphorylated form into an active, dephos- 
phorylated species [8]. This ‘peptide-like’ factor is 
believed to activate a protein phosphatase [7] 
although it also appears to inhibit a cyclic AMP- 
dependent protein kinase [7]. Indeed there have been 
a number of reports that insulin can affect the phos- 
phorylation of adipocyte proteins. The phosphoryla- 
tion of certain cytosol and endoplasmic reticulum 
proteins in intact adipocytes was apparently aug- 
mented by insulin [9,10] whereas the phosphoryla- 
tion of other endoplasmic reticulum and plasma 
membrane proteins may be inhibited [ 11 ,121. 
As the initial target of insulin’s action is the 
plasma membrane, we have used plasma membranes 
from rat liver to examine the effects of insulin on the 
phosphorylation of constituent proteins. The proteins 
of the plasma membrane have been resolved into 
peripheral proteins, those binding to the membrane 
by predominantly electrostatic interactions, and 
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integral proteins, those binding to the membrane 
through extensive hydrophobic interactions. It would 
appear that insulin triggers the cyclic AMPdependent 
phosphorylation of three_ peripheral proteins and 
inhibits the cyclic AMP-dependent phosphorylation 
of two integral proteins. 
2. Materials and methods 
Rat liver plasma membranes were prepared from 
250-300 g male Sprague-Dawley rats by the method 
in [13] asmodified [14]. 
Peripheral membrane proteins were separated from 
integral membrane proteins as in [ 151. Briefly this 
involved incubating for 45 min on ice, plasma mem- 
branes (4 mg protein) in a 3 ml cocktail containing 
(final cont.) 0.4 M NaCl, 20 mM Tris-HCl and 10 mM 
2-mercaptoethanol, at final pH 7.2. This mixture was 
then centrifuged at 300 000 X g, for 30 min at 4°C 
to yield a clear supernatant which contained the periph- 
eral proteins and a pellet containing the integral 
proteins. The pellet was resuspended in 1 mM KHC03 
(pH 7.2) and washed by ie-centrifugation prior to use. 
p[y-32~] ATP at spec. act. 200 mCi/mmol was pre- 
paredasin [16]. 
Sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) was done as in [ 171. 
This employed a 3% acrylamide stacking gel with an 
acrylamide :bis-acrylamide ratio of (30:0.8) and a 9% 
acrylamide separating gel keeping a similar acryl- 
amide:bis-acrylamide ratio (30:0.8). The stacking gel 
contained 0.125 M Tris-HCl buffer (pH 6.8) and the 
running gel 0.375 M Tris-HCl buffer (pH 8.8). As a 
routine 6 gels 7.5 cm long were electrophoresed at a 
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constant 3 mA for -4 h. Samples were prepared by 
mixing a 10 ~.tl sample containing 100 ug protein with 
a cocktail containing 6 mM EDTA, 0.75 M sucrose, 
6% SDS, 0.03% bromothymol blue at a final pH 7.4. 
Dithiothreitol(5 /.d, 160 mM) was added and the 
mixture incubated at 100°C for 5 min. After cooling, 
3 ~10.5 M iodoacetamide was added and the mixture 
incubated for 15 min at room temperature prior to 
electrophoresis. Gels were sliced into 1.5 mm sections 
which were individually incubated overnight in sealed 
1.5 ml plastic microfuge tubes containing 100 ~1 
40 mM Tris-HCl buffer (pH 7.4) containing 5 mM 
2-mercaptoethanol and 0.1% SDS. Samples (50 fl) 
were then taken for counting. These were each added 
to 4 ml cocktail of toluene:Triton:HzO (12:6:1.5; 
by vol.) containing 2.6 gPPO/l and counting was done 
on a Packard Tricarb 2425 Liquid Scintillation 
Spectrometer to 1% standard error. 
The phosphorylation reactions were done by 
incubating intact plasma membranes (500 1.18 protein/ 
ml) for 5 min at 30°C in a mixture containing (final 
cont.) 1 mM [Y-~‘P] ATP spec. act. 200 mCi/mmol, 
5 mM Mg&, 100 PM CaClz and 20 mM Tris-HCl at 
final pH 7.4 in 250 d final vol. To this mixture was also 
added various ligands and in some cases a protein 
kinase inhibitor prepared as in [ 181. The reaction was 
then either: 
(i) Quenched rapidly on ice and samples taken for 
electrophoresis; or 
(ii) Quenched by adding 1 ml icecold 1 mM KHC03 
(pH 7.2) and centrifuging for 6 min at 14 000 X gav 
at 4°C prior to separation of the peripheral and 
integral proteins for electrophoresis; or 
(iii) Quenched by adding 0.5 ml 10% cold trichloro- 
acetic acid and the pellet resuspended in 0.15 ml 
20 mM Tris-HCl (pH 7.4) and taken for electro- 
phoresis. 
All biochemicals were from Boehringer. Bovine 
insulin was from Sigma. Radiochemicals were from 
Amersham. Other chemicals were of the highest 
quality available from BDH. 
3. Results 
Incubation of rat liver plasma membranes with 
[T-~~P]ATP and various ligands for 5 min at 30°C 
followed by rapid quenching in trichloroacetic acid 
Fraction Number 
Fig.1. The effect of insulin and cyclic AMP on the phosphorylation of proteins in rat liver plasma membranes. The incorporation 
of szP from [T-~*P]ATP into protein resolved by SDS - PAGE of intact rat liver plasma membranes. Labelling was done as in 
section 2 and quenching was by trichloroacetic acid. Experiments were done with ATP alone (A); ATP + 10e9 M insulin (A); 
ATP + 4 X 10e6 M cyclic AMP (0); ATP + insulin + cyclic AMP (0). Experiments were also done in the presence of 4 pg protein/ 
ml pure cyclic AMP protein kinase inhibitor prepared as in [ 181. This was a kind gift from Dr H. G. Nimmo. For clarity the 
results obtained using this inhibitor and either ATP + cyclic AMP or ATP + cyclic AMP + insulin have been averaged and are 
shown as (0). This is because in both instances they are indistinguishable from background. We show here a typical experiment. 
Essentially similar results were obtained by quenching on ice prior to the preparation of samples for SDS-PAGE. 
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Fig.2. The resolution of the integral and peripheral proteins of rat liver plasma membranes and the effect of insulin and CYCliC 
AMP on their phosphorylation. After the native membranes were incubated with labelled ATP and the various Wnds, the mem- 
brane proteins were resolved into peripheral and integral species prior to SDS-PAGE. 
(a) Integral proteins: The effect of increasing insulin concentrations on the phosphorylation effected by 4 X 10e6 M cyclic AMP. 
The insulin concentrations were: zero (A); 5 X 10-r’ M (a); 2 x 10-r’ M (m); 5 x lo-l0 M (0); 1O-9 M (0). 
(b) Peripheral proteins: The effect of increasing insulin concentrations in the presence of 4 X lo-’ M cyclic AMP. The insulin 
concentrations were: 10-r’ M (A); 5 X lo-l1 M (a); 2 X 1O-*o M (m); 5 X 10-l” M (0); 10-g M (.). 
The concentration dependence of the phosphorylation of both these groups upon cyclic AMP is shown in f&3. The phosphoryla- 
tion of the peripheral proteins is dependent upon both cyclic AMP and insulin. These are typical results. 
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and SDS - PAGE led to the resolution of a number of 
bands of radioactivity (fig.1). Under the incubation 
conditions described, the labelling was essentially 
complete after this 5 min incubation and little signif- 
icant labelling occurred in the presence of ATP alone. 
The addition of cyclic AMP (4 X 10” M), however, 
caused two major bands to appear (Il,I2) and when 
bovine insulin (1 O-’ M) was added together with cyclic 
AMP, three major new labelled bands appeared 
(Pl -P3) whilst the two bands occurring in the pres- 
ence of cyclic AMP alone disappeared. Insulin by itself 
did not elicit the production of labelled bands from 
[Y-~~P]AT’P and the addition of a specific inhibitor of 
cyclic AMP-dependent protein kinase [ 181 blocked 
the production of labelled bands in instances where 
cyclic AMP was added. 
If after this incubation the reaction was quenched 
by ice-cold buffer and the integral and peripheral 
proteins resolved by a high ionic strength procedure, 
then upon SDS-PAGE the differences in the effects 
of insulin and cyclic AMP became apparent. For, in 
the presence of cyclic AMP alone, we observed that 
the two proteins labelled were in fact both integral 
proteins which we have designated 11,12. These have 
Mr 140 000 and 80 000, respectively (fig.2a). The 
labelling of the peripheral proteins of rat liver plasma 
membranes was only significant if both insulin and 
cyclic AMP were present together (2b,c). In this 
instance three major peaks were resolved which we 
have designated Pl , P2 and P3, having M, 52 000, 
28 000 and 14 000, respectively. 
When insulin and cyclic AMP were present together 
in the incubation then we observed that the integral 
proteins, 11 and 12, did not become labelled. How- 
ever, these proteins could be labelled by [y-32P]ATP 
in the presence of cyclic AMP, then the intact mem- 
branes washed by repeated centrifugation and resus- 
pension in icecold 1 mM KHCOa (pH 7.2). After this 
insulin (lo-* M) was added to these labelled, washed 
membranes suspended in a phosphorylation ‘cocktail’ 
lacking ATP. During incubation for 40 mm at 30°C 
the radioactivity associated with 11 and 12 remained 
constant. 
By carrying out experiments at different concen- 
trations of cyclic AMP and insulin, resolving the 
integral and peripheral components and running 
SDS-PAGE it was possible to obtain dose response 
curves for 32P incorporation into these proteins (fig.3). 
The effect of insulin on triggering the cyclic AMP- 
dependent phosphorylation of the peripheral pro- 
Fig.3. Dose response curves for the effects of insulin and 
cyclic AMP on the phosphorylation of peripheral and inte- 
gral proteins of rat liver plasma membranes. These data show 
typical experiments. 
(a) Peripheral proteins: The dose dependence of the phos- 
phorylation of Pl (a), P2 (0) and P3 (a) upon cyclic 
AMP in the presence of 10e9 M insulin. 
(b) Peripheral proteins: The dose dependence of the phos- 
phorylation of Pl (e), P2 (o) and P3 (a) upon insulin in 
the presence of 4 X 10e6 M cyclic AMP. 
(c) Integral proteins: The dose dependence of the phos- 
phorylation of I1 (0) and I2 (0) upon cyclic AMP. 
(d) Integral proteins: The dose dependence of the phos- 
phorylation of 11 (0) and I2 (0) upon insulin in the 
presence of 4 X 10m6 M cyclic AMP. 
Table 1 
The sensitivity of the phosphorylation of rat liver plasma 
membrane Integral and peripheral proteins to insulin 
and cyclic AMP 
Band K, insulin K, cyclic AMP 
(M-l) (M-‘) 
Pl 2.2 f 0.2 x 1O-‘O 1.6 f 0.15 X 1O-6 
P2 2.0 f 0.3 x lO“O 1.55 f 0.1 x 1o-6 
P3 2.1 f 0.2 x 1O-‘O 1.65 f 0.15 k 1O-6 
I1 2.1 ?r 0.2 x lo-‘0 2.4 f 0.2 X 1O-6 
I2 2.15 f 0.15 x lo-lo 2.55 f 0.15 x 10-e 
The labelled bands are designated in fig.1 and fig.2. The data 
is given + SD for 4 expt on different preparations 
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teins and in blocking the cyclic AMP-dependent phos- 
phorylation of the integral proteins, produced iden- 
tical &,-values of -lo-” M from the dose-response 
curves (table 1). However there appeared to be a 
significant difference in the &-values for the cyclic 
AMP dependence of the phosphorylation of the 
integral and peripheral proteins (P < .OOl). For, 
whilst the values were in the PM range, those 
expressed by the integral proteins were slightly higher 
than those expressed by the peripheral proteins 
(table 1). 
4. Discussion 
Unlike glucagon which appears to mediate its 
cellular effects by simply activating adenylate cyclase, 
hence elevating intracellular cyclic AMP levels, 
insulin stimulates a wide variety of cellular phenomena 
[ 1,4]. An occupied insulin receptor may express itself 
at the molecular level by directly acting upon several 
target proteins within the membrane; it may produce 
a specific ‘second messenger’ or it may achieve a com- 
bination of both. Our study demonstrates that the 
cyclic AMP-dependent phosphorylation of plasma 
membrane proteins is specifically affected as an 
immediate consequence of insulin binding to its 
receptor. Interestingly, insulin’s action on the integral 
membrane proteins is quite distinct from its action on 
the peripheral proteins. The two integral membrane 
proteins 11 and 12 (M, 140 000 and 80 000, respec- 
tively) which were phosphorylated by a cyclic AMP- 
dependent mechanism did not incorporate 32P from 
[y-32P]ATP when insulin was present. This could be 
due to insulin either inhibiting the action of a mem- 
brane-bound cyclic AMPdependent protein kinase or 
to a stimulation of a membrane-bound protein phos- 
phatase. Our experiments demonstrating that labelled 
I1 and 12 did not lose 32P when incubated with 
insulin, suggests that insulin inhibits a cyclic AMP- 
dependent protein kinase. On the other hand, the 
3 peripheral proteins that became labelled, only did 
so when both cyclic AMP and insulin were present 
together. It would appear that insulin triggers the 
cyclic AMP-dependent phosphorylation of these 
3 peripheral proteins. Whilst the K,-values were in the 
E.~M range, the cyclic AMP dependent of the phos- 
phorylation of the integral and peripheral proteins 
appeared to be significantly different. This could 
imply distinct cyclic AMP-dependent protein kinases 
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with different affinities for cyclic AMP and, 
importantly, a different response to insulin. 
However, the sensitivity of the phosphorylation of 
both the integral and peripheral proteins to insulin 
yielded similar K,-values of -10-r’ M, even though 
insulin blocked the labelling of the integral proteins 
but triggered that of the peripheral proteins. The 
Ka-value for this action of insulin is well within the 
physiological range and reflects the high affinity com- 
ponent observed in receptor binding studies [ 11. That 
obtained for cyclic AMP is rather intriguing, as basal 
intracellular cyclic AMP levels in the liver are likely to 
be 0.3-0.5 PM [ 19,201: too low to allow these phos- 
phorylation events to occur. However, after stimula- 
tion of liver cells by glucagon, cyclic AMP levels rise 
to 2-4 I.IM [21,22]. This would allow the phos- 
phorylation of the integral proteins to ensue and 
would allow the phosphorylation of the peripheral 
proteins to occur if insulin was present at an appro- 
priate concentration. It would appear that for insulin 
to achieve the effects observed in this study, intra- 
cellular cyclic AMP levels must first be elevated 
above their basal levels. This can be achieved by 
exposure of the cells to glucagon, and may reflect 
aspects of the mechanism by which these two hor- 
mones antagonise each other. Liver cells with intra- 
cellular cyclic AMP levels sufficiently high to allow 
the phosphorylation of these proteins such as may 
occur in some cancer and other abnormal states and 
during certain stages of the cell cycle [23,24] might 
be expected to exhibit very different responses to 
insulin compared with normal, resting liver cells. 
Of the proteins labelled in this study we are at 
present only able to identify one; the Mr 52 000 
peripheral species. This is a low Km cyclic AMP 
phosphodiesterase [25], which has been shown to be 
a peripheral enzyme [ 151 and is activated some 
2-fold only when insulin, cyclic AMP and ATP are 
added together to a plasma membrane preparation 
[25]. The K, for activation by insulin and cyclic 
AMP, at saturating concentrations of the other ligand, 
reflects that obtained in this study for the phos- 
phorylation of the peripheral species [25]. Presum- 
ably the activation of this enzyme, which can only 
occur after intracellular cyclic AMP levels have been 
elevated above their basal levels, explains why insulin 
can depress those elevated cyclic AMP levels achieved 
by glucagon, but does not affect basal levels [21]. 
This observation provides a molecular rationale for 
the proposal [21] that it is first necessary to elevate 
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cyclic AMP levels before they can be depressed by 
insulin. 
It is tempting to speculate on the nature of the 
other phosphoproteins, for example, insulin affects 
fluxes of Na’ and K’ across the plasma membrane [ 11. 
This may be due to the proposed effect of insulin 
preventing the cyclic AMP-mediated inhibition of the 
Na’/K’-ATPase [26]. If this were due to insulin 
blocking a cyclic AMP-dependent phosphorylation of 
a component of the Na+/K’-ATPase then 11 and 12 
would be candidates. Insulin is also reported to affect 
Na’:K’ exchange [27] and Ca2+ fluxes [ 11. These 
could be affected either by direct action on the inte- 
gral protein responsible or via a regulatory protein 
that is subject to cyclic AMP-dependent phosphoryla- 
tion like the M, 22 000 component regulating Ca2+ 
transport in cardiac sarcoplasmic reticulum [28]. The 
stimulating effect of insulin on amino acid transport 
may also be effected by a control of plasma mem- 
brane cyclic AMP-dependent protein kinases as 
y-aminoisobutyrate uptake into fibroblasts has been 
shown to be inhibited by a cyclic AMP-dependent 
protein kinase [28]. Indeed, in [29] insulin lowered 
the phosphorylation state and hence the activity of 
inhibitor-l in rat skeletal muscle. This inactivation of 
inhibitor-l relieves the inhibition on protein phos- 
phatase-1 which can then carry out reactions which 
inhibit glycogenolysis or activate glycogen synthesis 
[30,31]. As inhibitor-l is phosphorylated by a cyclic 
AMPdependent mechanism, this would be consistent 
with our proposal that insulin can modulate the 
activity of cyclic AMPdependent protein kinases. 
It is possible that the ‘peptide-like’ factor in [S--7], 
presumably released from the plasma membrane after 
occupancy of the insulin receptor, may be responsible 
for some or all of the effects observed. Alternatively 
one of the phosphoproteins we have identified may 
give rise to the production or release of such a factor. 
Our study demonstrates that in plasma membranes 
from liver, insulin has distinct effects on the cyclic 
AMP-dependent phosphorylation of specific integral 
and peripheral proteins. The concentration depen- 
dence upon insulin for the 5 proteins studied was 
identical and reflected that of insulin binding specif- 
ically with high affinity to its receptor. Occupancy of 
the insulin receptor allows the hormone to modulate 
a variety of cellular processes by initial actions at the 
plasma membrane. 
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